BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

OSLO, Norway--(BUSINESS WIRE)--NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized ...

CHICAGO, Oct. 11, 2023 /PRNewswire/ -- In the near future, HLA typing is poised to revolutionize the transplant industry. Rapid advancements in genomics and precision medicine will enable transplant ...

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.

The project aims to develop a library of T cells with specific receptors, ultimately contributing to development of a blood test for immunological fingerprinting.

A Medical University of South Carolina team reports in Frontiers in Immunology that it has engineered a new type of genetically modified immune cell that can precisely target and neutralize ...

A Medical University of South Carolina team reports in Frontiers in Immunology that it has engineered a new type of genetically modified immune cell that can precisely target and neutralize ...

In this interview, Dr. Heidt explains the contribution of Leiden University Medical Center to the immunological part of ULISES. First, could you explain the role of your team in ULISES? I am involved ...